Security record · archived quarter
XNCR
Xencor, Inc. · Healthcare · Biotechnology
13Tracked holders
n/aΔ holders
17.96MShares held
$339.91MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 28.41K | $397,905 | n/a | −1 |
| Q2 2026 | 80 | +2 | 51.89M | $834.92M | +6 | −4 |
| Q1 2026 | 81 | -4 | 48.47M | $584.53M | +2 | −7 |
| Q4 2025 | 85 | +1 | 50.89M | $779.05M | +3 | −1 |
| Q3 2025 | 16 | 0 | 41.61M | $488.08M | +1 | −2 |
| Q2 2025 | 14 | -1 | 41.55M | $326.56M | n/a | −1 |
| Q1 2025 | 12 | +2 | 20.83M | $221.62M | +3 | −1 |
| Q4 2024 | 10 | -2 | 20.65M | $474.47M | +1 | −3 |
| Q3 2024 | 11 | -2 | 20.50M | $412.29M | n/a | −2 |
| Q2 2024 | 13 | n/a | 17.96M | $339.91M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 9.12M | n/a | $172.57M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.96M | n/a | $75.01M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 1.44M | n/a | $27.22M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Point72 Asset Management ✦ | 1.26M | n/a | $23.89M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 820.87K | n/a | $15.54M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 501.61K | n/a | $9.50M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 268.58K | n/a | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 219.89K | n/a | $4.16M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 189.02K | n/a | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 65.32K | n/a | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 48.87K | n/a | $925,110 | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 12 | AQR Capital Management ✦ | 39.79K | n/a | $753,243 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Baillie Gifford ✦ | 23.53K | n/a | $445,423 | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 202 holders, 84.29M shares, $988.19M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API